Eagle Meds Services
Victoza (liraglutide) product image
Available to sourceHuman Prescription DrugDiabetes & Endocrine

LIRAGLUTIDE

6 mg/mL · Injection Solution
By Cipla USA Inc.
NDC
69097-920
Route
Subcutaneous
Therapeutic class
GLP-1 Receptor Agonist , Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
Marketing category
ANDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
LIRAGLUTIDE
NDC 69097-920